Trials / Completed
CompletedNCT00044434
Bupropion as a Smoking Cessation Aid in Alcoholics
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 200 (planned)
- Sponsor
- National Institute on Alcohol Abuse and Alcoholism (NIAAA) · NIH
- Sex
- All
- Age
- 25 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to test the use of time-released bupropion (Wellbutrin) in patients receiving treatment for alcohol abuse/dependence as an aid to stop smoking. Patients will receive either a time-released bupropion or placebo. Both groups will receive nicotine replacement therapy during the 9 week study. A final followup assessment will be conducted 6 months from the start of treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | bupropion (Wellbutrin) |
Timeline
- Start date
- 2002-05-01
- Primary completion
- 2005-04-01
- Completion
- 2005-04-01
- First posted
- 2002-08-30
- Last updated
- 2008-01-29
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00044434. Inclusion in this directory is not an endorsement.